Neuropeptide abnormalities in anorexia nervosa

Psychiatry Research

Volumn 62, Issue 1, 1996, Pages 65-74

  Kaye, Walter H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Anorexia nervosa; CRH; NPY; Opioids; Oxytocin; Vasopressin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NEUROPEPTIDE Y; OXYTOCIN; VASOPRESSIN;

AMENORRHEA; ANOREXIA NERVOSA; CONFERENCE PAPER; HUMAN; PRIORITY JOURNAL;

EID: 0029880058     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(96)02985-X     Document Type: Conference Paper

References (71)

1. Allen, Y.S., Adrian, T.E. and Allen, J.M. (1983) Neuropeptide Y distribution in the rat brain. Science 221, 877-879.
2. American Psychiatric Association (1987) DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders-Third Edition-Revised. American Psychiatric Press, Washington, DC.
3. Armeanu, M., Berkhout, G.M.J. and Schoemaker, J. (1992) Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment. Fertil Steril 57, 762-770.
4. Baraban, J.M., Walsh, B.T., Gladis, M., Roose, S.P., Dyrenfurth, I., Linkie, D. and Wiele, R.V. (1986) Effect of naloxone on luteinizing hormone secretion in eating disorders: a pilot study. Int J Eating Disorders 5, 149-155.
5. Baranowska, B. (1990) Are disturbances in opioid and adrenergic systems involved in the hormonal dysfunction of anorexia nervosa? Psychoneuroendocrinology 15, 371-379.
6. Baranowska, B., Rozbicka, G., Jeske, W. and Abdel-Fattah, M.H. (1984) The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and β-endorphine secretion. J Clin Endocrinol Metab 59, 412-416.
7. Berger, M., Pirke, K., Doerr, P., Krieg, C. and von Zerssen, D. (1983) Influence of weight loss on the dexamethasone suppression test. Arch Gen Psychiatry 40, 585-586.
8. Bissette, G. and Nemeroff, C.B. (1988) The role of neuropeptides in the pathogenesis and treatment of schizophrenia. In: Nemeroff, C.B. (Ed.), Neuropeptides in Psychiatric and Neurological Disorders. John Hopkins University Press, Baltimore, pp. 49-75.
9. Bohus, B., Kovacs, G.L. and De Weid, D. (1978) Oxytocin, vasopressin and memory: opposite effects on consolidation and retrial processes. Brain Res 157, 414-417.
10. Boyar, R.M., Hellman, L.D., Roffwarg, H.P., Katz, J., Zumoff, B., O'Connor, J., Bradlow, H.L. and Fukushima, D.K. (1977) Cortisol secretion and metabolism in anorexia nervosa. N Engl J Med 296, 190.
11. Boyar, R.M., Katz, J., Finkelstein, J.W., Kapen, S., Weiner, H., Weitzman, E.D. and Hellman, L. (1974) Anorexia nervosa: immaturity of the 24-hour luteinizing hormone secretory pattern. N Engl J Med 291, 861-865.
12. Brambilla, F., Cavagnini, F., Invitti, C., Poterzio, F., Lampertico, M., Sali, L., Maggioni, M., Candolfi, D., Panernai, E. and Muller, E.E. (1985) Neuroendocrine and psychopathological measures in anorexia nervosa: resemblances to primary affective disorders. Psychiatry Res 16, 165-176.
13. Brambilla, F., Ferrair, E., Petraglia, F., Facchinetti, F., Catalano, M. and Genazzani, A.R. (1991) Peripheral opioid secretory pattern in anorexia nervosa. Psychiatry Res 39, 115-127.
14. Britton, D.R., Koob, G.R., Rivier, J. and Vale, W. (1982) Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci 31, 363-367.
15. Casper, R.C., Chatterton, R.T. and Davis, J.M. (1979) Alterations in serum cortisol and its binding characteristics in anorexia nervosa. J Clin Endocrinol Metab 49, 406-411.
16. Chiodera, P., Volpi, R., Capretti, L., Marchesi, C., d'Amato, L., De Ferri, A., Bianconi, L. and Coiro, V. (1991) Effect of estrogen or insulin-induced hypoglycemia on plasma oxytocin levels in bulimia and anorexia nervosa. Metabolism 40, 1226-1230.
17. Clark, J.T., Kalra, P.S. and Kalra, S.P. (1985) Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology 117, 2435-2442.
18. Crowley, W.R. and Kalra, S.P. (1987) Neuropeptide Y stimulates the release of luteinizing hormone-releasing hormone from medial basal hypothalamus in vitro: modulation by ovarian hormones. Neuroendocrinology 46, 97-103.
19. Davies, P. and Terry, R.D. (1981) Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type. Neurobiol Aging 2, 9-14.
20. Demitrack, M.A., Lesem, M.D., Listwak, S.J., Brandt, H.A., Jimerson, D.C. and Gold, P.W. (1990) CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations. Am J Psychiatry 147, 882-886.
21. De Weid, D. (1965) The influences of the posterior and intermediate lobe of the pituitary and pituitary peptides on the maintenance of a conditioned avoidance response in rats. Int J Neuropharmacol 4, 157-167.
22. Donohoe, T.P. (1984). Stress-induced anorexia: implications for anorexia nervosa. Life Sci 34, 203-218.
23. Edelstein, C.K., Roy-Byrne, P., Fawy, F.I. and Dornsfeld, L. (1983) Effects of weight loss on the dexamathasone suppression test. Am J Psychiatry 140, 338-341.
24. Falk, C.R. and Halmi, K.A. (1982) Amenorrhea in anorexia nervosa: examination of the critical body weight hypothesis. Biological Psychiatry 17, 799-806.
25. Forsling, M.L. (1986) Regulation of oxytocin release. In: Pfaff, D. and Ganen, D. (Eds.), Current Topics in Neuroendocrinology, Vol. 6. Springer-Verlag, New York.
26. Fuxe, K., Agnati, L.F. and Harfstrand, A. (1983) Central administration of neuropeptide Y induces hypotension, bradypnea and EEG synchronization in the rat. Acta Physiologica Scandinavica 118, 189-192.
27. Garcia-Rubi, E., Vazquez-Aleman, D., Mendez, J.P., Salinas, J.L., Garza-Flores, J., Ponce-de-Leon, S., Perez-Palacios, G. and Ulloa-Aguirre, A. (1992) The effects of opioid blockade and GnRH administration upon luteinizing hormone secretion in patients with anorexia nervosa during the stages of weight loss and weight recovery. Clin Endocrinol 37, 520-528.
28. Giusti, M., Torre, R., Traverso, L., Cavagnaro, P., Attanasio, R. and Giordano, G. (1988) Endogenous opioid blockade and gonadotropin secretion: role of pulsatile luteinizing hormone-releasing hormone administration in anorexia nervosa and weight loss amenorrhea. Fertil Steril 49, 797-801.
29. Gold, P.W., Chrousos, G., Kellner, C., Post, R., Roy, A., Avgerinos, P., Schulte, H., Oldfield, E. and Loriaux, D.L. (1984) Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry 141, 619-627.
30. Gold, P.W., Gwirtsman, H., Avgerinos, P.C., Nieman, L.K., Gallucci, W.T., Kaye, W., Jimerson, D., Ebert, M., Rittmaster, R., Loriaux, D.L. and Chrousos, G.P. (1986) Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa: pathophysiologic mechanisms in underweight and weight-corrected patients. N Engl J Med 314, 1335-1342.
31. Gold, P.W., Kaye, W., Robertson, G.L. and Ebert, M. (1983) Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia nervosa. N Engl J Med 308, 1117-1123.
32. Grossman, A. (1983) Brain opiates and neuroendocrine function. J Clin Endocrinol Metab 12, 725.
33. Gwirtsman, H.E., Kaye, W.H., George, D.T., Jimerson, D.C., Ebert, M.H. and Gold, P.W. (1989) Central and peripheral ACTH and cortisol levels in anorexia nervosa and bulimia. Arch Gen Psychiatry 46, 61-69.
34. Haas, D.A. and George, S.R. (1987) Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions. Life Sci 41, 2725-2731.
35. Hokfelt, T., Hohansson, O. and Goldstein, M. (1984) Chemical anatomy of the brain. Science 225, 1326-1334.
36. Hotta, M., Shibasaki, T., Masuda, A., Imaki, T., Demura, H., Ling, N. and Shizume, K. (1986) The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients. J Clin Endocrinol Metab 62, 319-324.
37. Hudson, J.I., Pope, H.G., Jonas, J.M. and Yurgelun-Todd, D. (1983) Phenomenologic relationship of eating disorders to major affective disorder. Psychiatry Res 9, 345-354.
38. Jeuniewic, N., Brown, G.M., Garfinkel, P.E. and Moldofsky, J. (1978) Hypothalamic function as related to body weight and body fat in anorexia nervosa. Psychol Med 40, 187-198.
39. Kalra, S.P., Allen, L.G., Clark, J.T., Crowley, W.R. and Kalra, P.S. (1986) Neuropeptide Y - an integrator of reproductive and appetitive functions. In: Moody, T.W. (Ed.), Neural and Endocrine Peptides and Receptors. Plenum Press, New York, pp. 353-366.
40. Kaye, W.H., Berrettini, W.H., Gwirtsman, H.E., Chretien, M., Gold, P.W., George, D.T., Jimerson, D.C. and Ebert, M.H. (1987b) Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelancortin related peptides (including β-endorphin) in anorexia nervosa. Life Sci 41, 2147-2155.
41. Kaye, W.H., Berrettini, W., Gwirtsman, H. and George, D. (1990) Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Arch Gen Psychiatry 47 (6), 548-556.
42. Kaye, W.H., Gwirtsman, H.E., George, D.T., Ebert, M.H., Jimerson, D.C., Tomai, T.P., Chrousos, G.P. and Gold, P.W. (1987a) Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. J Clin Endocrinol Metab 64, 203-208.
43. Kaye, W.H., Pickar, D., Naber, D. and Ebert, M.H. (1982) Cerebrospinal fluid opioid activity in anorexia nervosa. Am J Psychiatry 139, 643-645.
44. Legros, J.J., Chiodera, P. and Demy-Ponsart, E. (1982) Inhibitory influence of exogenous oxytocin on adrenocorticotropin secretion in normal human subjects. J Clin Endocrinol Metab 55, 1-1039.
45. Leibowitz, S.F. (1984) Noradrenergic function in the medial hypothalamus: potential relation to anorexia nervosa and bulimia. In: Pirke, K.M. and Ploog, D. (Eds.), The Psychobiology of Anorexia Nervosa. Springer-Verlag, Berlin, p. 35.
46. Leibowitz, S.F. and Hor, L. (1982) Endorphinergic and α-noradrenergic systems in the para-ventricular nucleus: effects on eating behavior. Peptides 3, 421-428.
47. LeRoith, D., Shiloach, J., Roth, J. and Lesniak, M.A. (1988) Evolutionary origins of vertebrate hormones: substances similar to mammalian insulins are native to unicellular eukaryotes (Tetrahymena/Neurospora). Proc Natl Acad Sci USA 77, 6184-6188.
48. Lesem, M.D., Berrettini, W.H., Kaye, W.H. and Jimerson, D.C. (1991) Measurement of CSF dynorphin A 1-8 immunoreactivity in anorexia nervosa and normal-weight bulimia. Biological Psychiatry 29, 244-252.
49. Marrazzi, M.A. and Luby, E.D. (1986) An auto-addiction opioid model of chronic anorexia nervosa. Int J Eating Disord 5, 191-208.
50. Martin, J.B. and Reichlin, S. (1987) The neurohypophysis: physiology and disorders of secretion. In: Davis, F.A. (Ed.), Clinical Neuroendocrinology, 2nd Ed. Davis, Philadelphia, pp. 67-111.
51. Moore, R., Mills, I.H. and Forster, A. (1981) Naloxone in the treatment of anorexia nervosa: effect on weight. J R Soc Med 74, 129-131.
52. Morley, J.E. and Blundell, J.E. (1988) The neurobiological basis of eating disorders: some formulations. Biol Psychiatry 23, 53-78.
53. Morley, J.E., Levine, A.S., Gosnell, B.A., Kneip, J. and Grace, M. (1987) Effect of neuropeptide Y on ingestive behaviors in the rat. Am J Physiol 252, R599-R609.
54. Morley, J.E., Levine, A.S., Yim, G.K. and Lowry, M.T. (1983) Opioid modulation of appetite. Neurosci Biobehav Rev 7, 281-305.
55. Nemeroff, C.B., Widerlov, E., Bissette, G., Walleus, H., Karlson, I., Eklund, K., Lilts, C.D., Loosen, P.T. and Vale, W. (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226, 1342-1344.
56. Nybert, F., Wahlstrom, A., Sjolund, B. and Terenius, L. (1983) Characterization of electrophoretically separable endorphins in human CSF. Brain Res 259, 267.
57. Oram, J.J., Edwardson, J. and Millard, P.H. (1981) Investigation of CSF neuropeptides in idiopathic senile dementia. Gerontology 27, 216-223.
58. Pfeiffer, A. and Herz, A. (1984) Endocrine actions of opioids. Horm Metab Res 16, 386-397.
59. Recant, L., Voyles, N., Wade, A., Awake, S. and Bhothena, S.J. (1983) Studies on the role of opiate peptides in two forms of genetic obesity: ob/ob mouse fa/fa rat. Horm Metab Res 15, 589.
60. Rivier, C. and Vale, W. (1984) Influence of corticotropin-releasing factor on reproductive functions in the rat. Endocrinology 114, 914-921.
61. Rossor, M.N., Emson, P.C., Mountjoy, C.Q., Roth, M. and Iversen, L.L. (1980) Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of the Alzheimer type. Neurosci Lett 20, 373-377.
62. Sahu, A., Kalra, P.S. and Kalra, S.P. (1988) Food deprivation and ingestion induces reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides 9, 83-86.
63. Sirinathsinghji, D.J., Rees, L.H., Rivier, J. and Vale, W. (1983) Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature 305, 232-235.
64. Smith, S.R., Bledsoe, T. and Chhetri, M.K. (1975) Cortisol metabolism and the pituitary-adrenal axis in adults with protein-calorie malnutrition. J Clin Endocrinol Metab 40, 43.
65. Stanley, B.C., Daniel, D.R., Chin, A.S. and Leibowitz, S.F. (1985) Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion. Peptides 6, 1205-1211.
66. Stanley, B.C. and Leibowitz, S.F. (1984) Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 35, 2635-2642.
67. Sutton, R.E., Koob, G.F., LeMoal, M., Rivier, J. and Vale, W. (1982) Corticotropin-releasing factor produces behavioural activation in rats. Nature 297, 331-333.
68. Szmukler, G.I. and Tantam, D. (1984) Anorexia nervosa: starvation dependence. Br J Med Psychol 57, 303-310.
69. Tepper, R., Weizman, A., Apter, A., Tyano, S. and Beyth, Y. (1992) Elevated plasma immunoreactive β-endorphin in anorexia nervosa. Clin Neuropharmacol 5, 387-391.
70. Tseng, L. and Cheng, D.S. (1980) Acute and chronic administration of β-endorphin and naloxone on food and water intake in rats. Fed Proc 39 (No. 1806 abstract), 606.
71. Widerlov, E. (1988) The future of neuropeptides in psychiatry and neurology. In: Nemeroff, C.B. (Ed.), Neuropeptides in Psychiatric and Neurological Disorders. John Hopkins University Press, Baltimore, pp. 281-306.